Posts Tagged ‘Medicare’

Unregulated prescription of antipsychotic drugs in elder care facilities on the rise

Monday, May 16th, 2011

Santa Cruz Sentinel -  May 15, 2011

A recent study by the Office of the Inspector General of the United States indicates that residents of some nursing homes may be regularly given atypical antipsychotic drugs as a means of chemical restraint, sometimes to the detriment of their health, including death.

The report, published May 9, states: “For the period January 1 through June 30, 2007, we determined using medical record review that 51 percent of Medicare claims for atypical antipsychotic drugs were erroneous.”

A member of Congress requested the office evaluate the extent to which nursing home residents receive atypical antipsychotic drugs and the associated cost to Medicare. The member expressed concern with these drugs were being prescribed for off-label conditions — i.e. conditions other than schizophrenia and/or bipolar disorder — and/or in the presence of a condition specified in the Food and Drug Administration’s boxed warning.

“We determined that 83 percent of Medicare claims for atypical antipsychotic drugs for elderly nursing home residents were associated with off-label conditions and that 88 percent were associated with the condition specified in the FDA boxed warning,” the Office of the Inspector General found.

The California Advocates for Nursing Home Reform has been concerned about this issue for some time. For more information, visit www.canhr.org/help.html

http://www.santacruzsentinel.com/ci_18067580


« Return to news items


Share

Antipsychotic Drugs Called Hazardous for the Elderly

Monday, May 9th, 2011

The New York Times
By Gardiner Harris
May 9, 2011

Nearly one in seven elderly nursing home residents, nearly all of them with dementia, are given powerful atypical antipsychotic drugs even though the medicines increase the risks of death and are not approved for such treatments, a government audit found.

More than half of the antipsychotics paid for by the federal Medicare program in the first half of 2007 were “erroneous,” the audit found, costing the program $116 million for those six months.

“Government, taxpayers, nursing home residents as well as their families and caregivers should be outraged and seek solutions,” Daniel R. Levinson, inspector general of the Department of Health and Human Services, wrote in announcing the audit results.

Mr. Levinson noted that such drugs — which include Risperdal, Zyprexa, Seroquel, Abilify and Geodon — are “potentially lethal” to many of the patients getting them and that some drug manufacturers illegally marketed their medicines for these uses “putting profits before safety.”

The audit is an unusual assessment by the government of whether doctors are treating Medicare patients appropriately in nursing homes. Mr. Levinson suggested that the government should collect information on the diagnoses given Medicare patients so that the government can assess whether the drugs prescribed to them are appropriate.

While common in the private sector, such basic oversight is unheard of in the Medicare program and would almost certainly be opposed by doctors’ groups and many in Congress who view government intrusions into the doctor-patient relationship as inappropriate. In response to the audit, the Centers for Medicare and Medicaid Services said that some of the inappropriate use of antipsychotics in elderly nursing home patients is a result of drug makers’ paying kickbacks to nursing homes to increase prescriptions for the medicines.

Omnicare Inc., a pharmacy chain for nursing homes, paid $98 million in November 2009 to settle accusations that it received kickbacks from Johnson & Johnson and other drug makers for antipsychotic prescriptions.

Medicare officials said that diagnosis information is not generally included with prescriptions so the government cannot assess in real time whether prescription payments are appropriate.

While the Food and Drug Administration has warned doctors that using antipsychotic drugs in elderly patients with dementia increases their risks of death, doctors continue the practice because they have few other good choices, said Dr. Daniel J. Carlat, editor in chief of The Carlat Psychiatry Report, a medical education newsletter for psychiatrists.

“Doctors want to maximize quality of life by treating the patient’s agitation even if that means the patient will die a bit sooner,” Dr. Carlat said.

The government auditors found that of the 2.1 million elderly patients in nursing homes during the first six months of 2007, 304,983 had at least one Medicare claim for an antipsychotic medicine. Nursing home residents received 20 percent of the 8.5 million claims for antipsychotic medicines for all Medicare beneficiaries at a cost of $309 million during those six months.

The auditors found that 83 percent of antipsychotic prescriptions for elderly nursing home residents were for uses not approved by federal drug regulators, and 88 percent were to treat patients with dementia — for whom the drugs can be lethal.

“These results are alarming,” said Senator Charles E. Grassley, Republican of Iowa, who asked for the audit. “Medicare officials need to pay attention.”

Federal rules require that any drugs that are paid for by the government be given only for uses that are approved either by the government or one of three independent drug usage encyclopedias. Auditors found that 51 percent, or 726,000 of 1.4 million claims, for antipsychotic medicines did not meet this criterion and were thus paid for by the government improperly.

Government rules also ban drugs that are used in excessive doses or duration, even if patients are found to have a condition for which the drug is appropriate. Auditors found that 22 percent, or 317,971 of 1.4 million claims, for antipsychotic medicines failed this standard.

Read article here:  http://www.nytimes.com/2011/05/10/health/policy/10drug.html?_r=2

« Return to news items


Share

Brooklyn’s Kingsboro Psychiatric Center a ‘violent’ madhouse with deaths linked to paperwork snafus

Sunday, May 8th, 2011

NY Daily News
By Jake Pearson
May 8, 2011

Kingsboro Psychiatric Center has failed four consecutive federal surveys by Center of Medicare and Medicaid Services. (Nicholas Fevelo for News)

A Brooklyn mental hospital is a violence-wracked, dangerous place, rife with assaults and at least two deaths linked to paperwork snafus, the Daily News has learned.

Federal surveys and court documents paint a disturbing portrait at the state’s problem-plagued Kingsboro Psychiatric Center.

“Violence has become a way of life at KPC,” an independent mental health expert wrote in a Kingsboro-commissioned 2009 report after the hospital was sued in federal court.

“Patient and staff injury are a matter of course – it’s an expected part of the hospital routine,” wrote Dr. Jeffrey Geller of the University of Massachusetts.

He said the culture at the Flatbush hospital had become about “providing room, board and medication; and doing one’s best to stay out of harm’s way.”

The hospital failed four consecutive federal surveys by Center of Medicare and Medicaid Services – and withdrew from the federal funding program, losing $22.5 million in Medicaid funds.

“This is the worst I’ve ever seen. Everyone’s complaining, from doctors to nurses to social workers. What we have is management that is grossly incompetent,” one hospital source said. “We lost a lot of money.”

The findings and allegations in a still-pending suit filed by the Mental Hygiene Legal Service include:

  • Two patients – called L1 and L2 in a January 2010 CMS report – may have died after paperwork mixups and “layers of bureaucracy” delayed their treatment. The patients had refused medicine or medical procedures, and the hospital dragged its heels in getting a judge to order the treatment.

A doctor for one of the patients told investigators the deaths were a “tough lesson” and demonstrated the need to “be more assertive and aggressive” in treating patients.

  • Mental Hygiene lawyers said a “frail, nearly crippled 77-year-old woman with paralyzed vocal cords” was beaten badly by her roommate and suffered severe facial bruising.
  • One patient, identified as Vadim B., was badly beaten by another patient, who then threatened to stab him to death.

A spokeswoman for the State Office of Mental Health insisted Kingsboro officials have taken steps since 2009 to quell the violence and improve care, like replacing clinical and leadership team members.

“Our reform efforts are ongoing,” spokeswoman Jill Daniels said.

Still, elected officials insist it’s time for new leadership at Kingsboro. “You have employees who are assaulted and patients with special needs – these are an extremely vulnerable group of people that are not getting the proper care they deserve,” said state Sen. Eric Adams (D-Brooklyn). “We are failing, but no one is willing to change leadership at the top.”

Fitzroy Wilson, president of the Civil Service Employees Association union local 402, said something needed to be done to end the violence at Kingsboro.

“Staff shortages and the lack of specific training are responsible for the patient violence and it interferes with proper patient care,” he said. “Violence at Kingsboro is rampant and widespread.”

Read article here:  http://www.nydailynews.com/ny_local/2011/05/08/2011-05-08_bklyn_psych_facility_a_violent_madhouse.html

« Return to news items


Share

First Miami defendant in nation’s biggest mental healthcare fraud case pleads guilty

Thursday, April 14th, 2011

Note from CCHR:  Governments and private health insurance companies have provided the mental health industry with billions of dollars every year to treat “mental illness,” only to face industry demands for even more funds to improve the supposed, ever-worsening state of mental health. No other industry can afford to fail consistently and expect to get more funding.  A significant portion of these appropriations and insurance reimbursements has been lost due to financial fraud within the mental health industry, an international problem estimated to cost more than a hundred billion dollars every year.

  • The United States loses approximately $100 billion to health care fraud each year. Up to $20 billion of this is due to fraudulent practices in the mental health industry.
  • One of the largest health care fraud suits in US history was in mental health, yet it is the smallest sector within health care.
  • A study of US Medicaid and Medicare insurance fraud, especially in New York, over a twenty-year period, showed psychiatry to have the worst track record of all medical disciplines.
  • To find out more, download this free report from Massive Fraud: Psychiatry’s Corrupt Industry http://www.cchr.org/sites/default/files/CCHR_Pamphlet_Massive_Fraud_1.pdf

The Miami Herald

by Jay Weaver

The first Miami defendant in the nation’s largest mental healthcare fraud case pleaded guilty to paying millions of dollars in kickbacks in exchange for Medicare patients who didn’t need the costly therapy.

Her job as marketing director for a Miami-based mental healthcare chain was to bring in the patients and nobody did their job better than Margarita Acevedo.

Investigators say she paid millions of dollars in kickbacks to South Florida assisted-living facilities, halfway houses and recruiters to supply thousands of Medicare beneficiaries to American Therapeutic Corp.’s chain of seven clinics — patients who didn’t need the costly treatment.

On Thursday, Acevedo, 41, of Southwest Miami-Dade, pleaded guilty to conspiring to pay kickbacks in exchange for patients and conspiring to bilk between $100 million and $200 million from Medicare, in the largest mental healthcare fraud case in the country.

Her change of plea in a Miami federal court makes Acevedo the first defendant among 24 indicted since last fall to admit playing a role in American Therapeutic’s “massive fraud scheme” against the taxpayer-funded healthcare program for seniors and the disabled, according to court records.

She faces between 12 and 15 years in prison at her mid-July sentencing, according to sentencing guidelines.

Prosecutors are expected to recommend a lesser sentence because she is providing the Justice Department with an insider’s view of the alleged racket.

Her attorney, Ira Loewy, declined to comment Friday on her cooperation with authorities.

Acevedo, who joined American Therapeutic in 2005, admitted in a “factual” statement that “in her role as a manager, she worked with the [company] leaders and organizers in recruiting ALF and halfway house owners and supervised co-conspirators in tracking and paying the kickbacks.”

For their part, the residential operators acted as recruiters who took bribes from American Therapeutic’s clinics – $30 for each patient’s daily visit – for supplying thousands of Medicare beneficiaries to keep the racket rolling, authorities say.

American Therapeutic, founded in 2000, allegedly ran its operation for years, tapping into a stream of mentally ill patients who were supposed to have received treatment in local hospitals before qualifying for outpatient group therapy sessions.

Despite conspicuously high claims, the Medicare program never raised an eyebrow. Things began to unravel years later when clinic employees started complaining that many patients were beyond help because they suffered from dementia or Alzheimer’s disease. One employee was fired, leading to a whistle-blower probe of American Therapeutic that became the foundation of the criminal investigation.

Acevedo’s bosses were Lawrence Duran, 48, of North Miami, and Marianella Valera, 39, of Miami, owners of American Therapeutic. They were charged with directing the conspiracy to defraud the Medicare program, leading a network of company employees, psychiatrists and patient recruiters who also face criminal charges.

In March, the couple’s lawyers told U.S. District Judge James Lawrence King that they plan to plead guilty, but they have not done so yet. Their trial is set for August.

Duran and Valera were poised to change their initial not guilty pleas, but a major dispute over how much the couple allegedly bilked from Medicare held up everything. Their lawyers, Lawrence Metsch and Arthur Tifford, have argued that the figure should be $83 million, the actual amount the federal program paid their company since 2003.

Justice Department attorney Jennifer Saulino has argued that the figure should be about $200 million, the amount their company billed Medicare during that period.

The feds have frozen the couple’s personal and corporate bank accounts, Saulino said. They also possess about $7 million in assets, such as luxury cars, real estate and jewelry, that authorities seized with a temporary restraining order.

. Duran, who was born in New York, and Valera, a native of Peru, are being held at the Federal Detention Center in Miami because a judge found both to be a flight risk.

To read more about psychiatric health care fraud


« Return to news items


Share

Electroconvulsive Therapy: Will The FDA Whitewash It?

Tuesday, December 28th, 2010

The Huffington Post—December 28 , 2010

by Dr. Peter Breggin

For decades the FDA has allowed electroconvulsive therapy (ECT) to be used without requiring any proof of safety or efficacy. The machines and the treatment has been “grandfathered” into use rather than tested. A few years ago the FDA proposed to test the treatment but heavy pressure from the American Psychiatric Association caused the agency to reverse itself. ECT remains untested and widely used. Imagine that — the American Psychiatric Association doesn’t want an obviously dangerous treatment to be tested at all.  It just wants psychiatrists left alone to inflict it upon hapless patients.

Now the FDA is reconsidering whether to officially approve ECT without testing and it seems inclined to do so. Given the strength and influence of the American Psychiatric Association, we can anticipate results that will whitewash the dangers and allow the continued use of ECT unhampered by scientific testing. The hearings are scheduled for January 27 and 28, 2011. Anyone can attend and I encourage all interested citizens to get involved by contacting the FDA and asking for time to make a brief presentation.

I have written to the FDA explaining that the treatment has so little efficacy and is so obviously damaging — it routinely produces an acute state of delirium and confusion with severe memory loss — that it should be banned. That document has now been published in two scientific journals. It supplements my chapter on ECT in Brain-Disabling Treatments in Psychiatric: Drugs, ECT and the Psychopharmaceutical Complex, Second Edition (2008).

As I noted in my scientific article and my 2008 book, and in a previous blog, Sackeim and colleagues from the heart of the psychiatric establishment once again confirmed that ECT routinely produces long-term dementia in the form of multiple memory loss in combination with other persistent cognitive deficits. Now a new scientific analysis has confirmed all the bad news about ECT.

The recent review of the scientific literature by John Read (New Zealand) and Richard Bentall (Great Britain) found that ECT treatments show only the most minimal evidence for improvement during the treatment and no evidence for improvement afterward. As my own research confirms, they found no evidence that ECT reduces the suicide rate.

Read and Bentall summarized “strong evidence” for “persistent and, for some, permanent brain dysfunction.” They concluded that “the cost-benefit analysis for ECT is so poor that its use cannot be scientifically justified.” They further stated, “The continued use of ECT therefore represents a failure to introduce the ideals of evidence-based medicine into psychiatry.”

The sad truth is that psychiatry has always promoted brain-damaging treatments, including lobotomy, electroshock and toxic chemical substances. In the 1970s I conducted an intensive international campaign to stop the resurgence of lobotomy and others forms of psychosurgery, and if my campaign had not been successful, lobotomy would have once again become widely accepted within contemporary psychiatry. Using media citations and other sources, that campaign and its success is documented in The Conscience of Psychiatry: The Reform Work of Peter R. Breggin, MD.

Because ECT advocates have successfully lobbied against the states collecting data on ECT use, we can only speculate about the numbers of patients subjected to this treatment. Probably it is at least in the range of 150,000 to 200,000 per year. Most large cities have several facilities doing ECT including private psychiatric hospitals and university hospitals and general hospitals with psychiatric wards.

Elderly women on Medicare are the most frequent victims of this anachronistic abuse, but anyone who gets depressed and overwhelmed with feelings of helplessness can become vulnerable. It’s not your mental condition as much as your doctor’s moral condition that determines whether you get pushed into taking ECT. Recently I’ve encountered three relatively young physicians whose professional lives were ruined by ECT-induced mental dysfunction.

It’s time for public outrage and it’s time for the FDA to close the door on this abusive “treatment.”

Peter R. Breggin, M.D. is a psychiatrist in private practice in Ithaca, New York, and the author of dozens of scientific articles and more than twenty books. His two most recent books are Medication Madness: The Role of Psychiatric Drugs in Cases of Violence, Suicide and Crime and Brain-Disabling Treatments in Psychiatry, Second Edition: Drugs, Electroshock and the Psychopharmaceutical Complex. Dr. Breggin and his wife Ginger have founded a new organization, The Center for the Study of Empathic Therapy, Education and Living (empathictherapy.org). It will hold an international conference in Syracuse, New York, April 8-10, 2011. It’s time to sign up!

The Dr. Peter Breggin Hour appears weekly on the Progressive Radio Network where it is archived for convenient listening. Dr. Breggin’s professional website is www.breggin.com.

« Return to news items


Share

Nursing homes are seeking to end the psychiatric drug stupor

Sunday, December 5th, 2010

Note from CCHR: The wholesale psychiatric drugging of the elderly in both private and public nursing homes has reached epidemic levels, with the use of antipsychotics, antianxiety drugs (tranquilizers) and antidepressants  skyrocketing and patients being harmed and killed as a direct result.  These drugs are highly dangerous when prescribed to anyone, but when prescribed to the elderly the risks for diabetes, stroke and sudden death are greatly increased.    As stated in the article below, ” Instead of looking for causes of disruptive behavior among dementia patients, doctors typically prescribe drugs to mask the symptoms… because it’s the easy thing to do. … That’s true in hospitals, in clinics and in nursing homes.” It is for this reason we feel the more humane non-drug approach being undertaken by this particular chain of nursing homes in treating elderly patients  suffering from dementia should not only be commended, but employed by all nursing homes caring for the elderly.

The Star Tribune – Dec 4, 2010

by Warren Wolfe

Instead of treating behavioral problems with antipsychotic drugs, the Ecumen chain of 15 homes is using strategies including aromatherapy, massage, music, games, exercise and good talk. The state is helping out.

The aged woman had stopped biting aides and hitting other residents. That was the good news.

But in the North Shore nursing home’s efforts to achieve peace, she and many other residents were drugged into a stupor — sleepy, lethargic, with little interest in food, activities and other people.

“You see that in just about any nursing home,” said Eva Lanigan, a nurse and resident care coordinator at Sunrise Home in Two Harbors, Minn. “But what kind of quality of life is that?”

Working with a psychiatrist and a pharmacist, Lanigan started a project last year to find other ways to ease the yelling, moaning, crying, spitting, biting and other disruptive behavior that sometimes accompany dementia.

They wanted to replace drugs with aromatherapy, massage, games, exercise, personal attention, better pain control and other techniques. The entire staff was trained and encouraged to interact with residents with dementia.

Within six months, they eliminated antipsychotic drugs and cut the use of antidepressants by half. The result, Lanigan said: “The chaos level is down, but the noise is up — the noise of people laughing, talking, much more engaged with life. It’s amazing.”

Now the home’s operator, Shoreview-based Ecumen, has started a project called Awakenings throughout its 15 long-term care nursing homes. It’s based on Lanigan’s work and funded with a two-year, $3.7 million state grant.

“We saw what Eva was doing — something everybody in the industry talks about — and we were impressed,” said Mick Finn, an Ecumen vice president. “We said, ‘Hey, this is real. Can we all do this?’ ”

The dangers of drugs

Powerful antipsychotic drugs have been used for years to reduce agitation, hallucinations and other debilitating symptoms among people with mental illnesses.

They also are widely used “off label” to quell disruptive behavior among people with Alzheimer’s disease and other forms of dementia.

Medicare spends more than $5 billion a year on those drugs for its beneficiaries, including about 30 percent of nursing home residents. Several studies have concluded that more than half are prescribed inappropriately. The drugs are especially hazardous to older people, raising the risk of strokes, pneumonia, confusion, falls, diabetes and hospitalization.

“There’s a bunch of problems, not least of which is those drugs can kill you,” said Dr. Mark Kunik at Baylor College of Medicine in Houston who spoke last month at the Gerontological Society of America’s annual meeting in New Orleans.

Instead of looking for causes of disruptive behavior among dementia patients, doctors typically prescribe drugs to mask the symptoms, he said, because “It’s the easy thing to do. … That’s true in hospitals, in clinics and in nursing homes.”

Federal regulators are cracking down on homes that don’t routinely reassess residents on psychotropic drugs. But use remains widespread.

“Whether you have Alzheimer’s or not, there’s a reason people get frustrated or upset — pain, urinary tract infections, hunger, fear of strangers or loud noises or strange settings, maybe drug interactions,” Kunik said. “If you figure that out, you likely can find a safer, nonpharmacologic treatment.”

Treating loss with love

About 150 miles south of Two Harbors, Bernice Brockelman, 91, was snacking on cookies last Wednesday beside the Christmas tree at Ecumen Parmly LifePointes, a nursing home in Center City — all the while alternating quickly from calm to worry to calm.

“Can I stay here tonight? I don’t know where to go. Can I stay with you?” she asked Christy Johnson, the home’s therapeutic recreation director. Though Johnson reassured her, she asked the question again — and again and again.

In an effort to calm her while preparing to wean her from pills, the Parmly staff invited Brockelman into a game of Bingo and to recite the Polish phrases she learned from her immigrant parents. Then she spotted a male visitor.

“Hey, is he married?” she asked with a sparkle in her eye.

“When she’s feeling good, Mom’s an outrageous flirt and she can be really funny,” said her daughter, Judy Balthazor of Center City. “But often there is the repetitive questions, the worry, sometimes just being washed out. I can’t wait for them to get her off her drugs.”

Until the Awakenings project, few at the home knew Brockelman’s whole story — the loss of both parents when she was in high school, of her husband at age 46, then two sons, a close friend and a nephew. Found to have psychosis and dementia, she “just shut down because she had so many losses,” Balthazor said.

Now, the Parmly staff is gaining deeper knowledge of 15 residents who are on psychotropic drugs and who frequently are agitated or upset. They are about to start weaning the residents from the drugs, but they’ve already started a range of activities tailored to each.

Some say nursing homes cannot afford to replace drugs with personal attention because it requires too much staff time.

“Our guess is that it will take the equivalent of two extra people at each home, spread across all job categories,” said Finn, Ecuman’s vice president. “Can we afford it? We think we have to, because it’s the right thing.”

Brockelman, who lived nearly all of her life in northeast Minneapolis, loved to bake, so now she helps make bread and cookies. She danced and was physically active, so she walks with an aide and taps her toes to polka music. A devout Catholic, she attends several weekly church services. She plays Bingo with aide Jenna Miller and sometimes other residents.

“When [you] understand who Beatrice has been in the past, you know her a lot better in the present,” Miller said. “With the Awakenings project, I have permission to spend the time I need with Bernice so she feels safe and loved.”

http://www.startribune.com/lifestyle/health/111326224.html?page=1&c=y

« Return to news items


Share

Psychiatrist on Payroll of Glaxo Pleads Guilty to Research Fraud

Monday, November 29th, 2010

NaturalNews, November 29,2010

by David Gutierrez

GlaxoSmithKline, manufacturer of Paxil, paid Palazzo $5,000 for every child she enrolled in the study.

A psychiatrist on the payroll of GlaxoSmithKline has been sentenced to 13 months in prison after pleading guilty to committing research fraud in trials of the company’s antidepressant Paxil on children.

Maria Carmen Palazzo is already serving a sentence of 87 months for defrauding Medicare and Medicaid.

Palazzo was accused by the FDA of enrolling children in a clinical trial even though she knew they did not actually suffer from major depressive or obsessive compulsive disorder, the conditions being studied. Palazzo then falsified records and psychiatric diagnoses.

GlaxoSmithKline, manufacturer of Paxil, paid Palazzo $5,000 for every child she enrolled in the study.

The case’s significance goes beyond simple research fraud, as Glaxo is now defending itself against charges that for 15 years it deliberately concealed evidence that Paxil increases the risk of suicide in children.

Glaxo is also defending itself against accusations that it manipulated data to conceal the risks of its diabetes blockbuster Avandia, and that it failed to warn parents that Paxil may cause birth defects if taken by pregnant women. The company has already agreed to pay more than $1 billion to settle roughly 700 birth defect lawsuits; another 100 or so suits are pending.

Although the FDA eventually required Paxil to carry a warning about the risk of birth defects and an even more prominent “black box” warning about suicide risk, many critics allege that the agency acted too slowly.

“There [had] been hints for many years that antidepressants, such as Paxil, when given to children, can cause serious side effects, including suicide, but the FDA delayed taking any action to prevent these drugs from being prescribed for children,” writes Brent Hoadley in Too Profitable to Cure.

Palazzo will not actually serve any additional prison time for potentially placing children’s safety at risk; her new term will be served concurrently with her first.

http://www.naturalnews.com/030557_psychiatry_fraud.html

« Return to news items


Share

EDITORIAL: Why are doctors writing so many prescriptions?

Friday, November 5th, 2010

TuscaloosaNews

November 5, 2010

ALABAMA: No doubt, Robert Bentley’s ‘to do’ list is growing daily as he prepares to become Alabama’s next governor, but we hope he will add this: getting the state’s Medicaid agency to release information on prescriptions written for expensive drugs.

U.S. Sen. Charles Grassley, R-Iowa, has been gathering information from across the nation to see why some doctors are writing stunning numbers of prescriptions that are paid for by taxpayers. Most states have provided this data; Alabama has not.

It is important because, as it turns out, some doctors are writing far more prescriptions for psychiatric drugs than are their colleagues. Not only does this add to the strain on Medicaid and Medicare, but it may indicate that some patients are being over-medicated.

Grassley, a member of the Senate Finance Committee, wrote to state Medicaid agencies earlier this year, asking them to list their top 10 prescribers of eight drugs commonly used in psychiatry. It may be that these doctors have good reasons for writing the most prescriptions for these drugs, such as OxyContin and Xanax, but it might also point out instances of overuse or even fraud.

In Florida, for example, one physician wrote 96,685 prescriptions for mental health drugs over a 21-month period. That works out to more than 150 prescriptions a day, seven days a week, for nearly two years.

Alabama refused to provide the senator with the information he requested. The response was that this information might be misinterpreted and these doctors may have

legitimate reasons for writing so many scrips.

Indeed, but the best way to provide an explanation is with more information, not less. If these doctors are asking the public to pay for these drugs, there should be some public accountability.

(Note from CCHR Int: Yep…)

Read the rest of the article here:  http://www.tuscaloosanews.com/article/20101105/NEWS/101109818/1012?p=2&tc=pg

« Return to news items


Share

Grassley: Are high prescription rates a sign of fraud?

Monday, October 25th, 2010

Fierce Health Care, October 25, 2010

by Sandra Yin

A Miami doctor wrote nearly 97,000 prescriptions in 18 months for mental health drugs. An Ohio physician wrote more than 100,000 prescriptions in two years. A Texas doctor wrote more than 14,000 prescriptions for the anti-anxiety drug Xanax. These alarmingly high prescriptions numbers for mental health drugs covered by Medicare and Medicaid have prompted Senator Charles Grassley (R-Iowa) to call for an investigation, the Associated Press reports.

“The federal government has an obligation to figure out what’s going on here,” he wrote in an email sent to the AP last week. “The taxpayers are footing the bill, and Medicare and Medicaid are already strained to the limit. These programs can’t spare a dollar for prescription drugs that aren’t properly prescribed.”

Grassley, a ranking member of the Senate Finance Committee, which oversees Medicare and Medicaid, noted that it’s possible there wasn’t any fraud. Still, he maintained the importance of clarifying what was going on and fixing whatever was broken. His comments came after he sent a letter to Department of Health and Human Services Secretary Kathleen Sebelius and Centers for Medicare and Medicaid chief Donald Berwick, complaining that CMS wasn’t doing enough to oversee contractors to prevent fraud and abuse.

Read more: http://www.fiercehealthcare.com/story/grassley-are-high-prescription-rates-sign-fraud/2010-10-25#ixzz13PcCmScJ

« Return to news items


Share

Top prescribers under Senate’s microscope

Monday, October 25th, 2010

U.S. Sen Charles Grassley, R-Iowa, examined Minnesota doctors as part of his investigation into the overprescription of drugs, at great cost to Medicaid and Medicare.

Star Tribune
By Jeremy Olson
October 25, 2010

Minnesota doctors are again under the microscope of an influential U.S. senator from Iowa — this time because of concerns that expensive medications are being overprescribed at great cost to the publicly funded Medicaid and Medicare programs.

U.S. Sen. Charles Grassley, R-Iowa, notified federal authorities Wednesday that he found potential examples of overprescribing after requesting lists from states, including Minnesota, of doctors who issued the most prescriptions for antipsychotic and narcotic medications in 2008 and 2009.

The most egregious example, cited in a letter to Health and Human Services Secretary Kathleen Sebelius, was a Florida doctor who wrote 96,685 prescriptions for mental health drugs in 21 months and billed the cost to the state’s Medicaid program.

Grassley’s letter mentioned no Minnesota physicians, instead pointing out doctors in Ohio, Oklahoma and South Dakota who prescribed many more high-cost drugs than their colleagues to poor and disabled Medicaid patients.

Grassley’s findings don’t prove fraud or overprescribing, but they could cause doctors to be removed from participating in Medicare and Medicaid, government health programs that, between them, insure some 100 million elderly, poor and disabled Americans. He urged federal authorities to pick up the trail.

“This trend is found again and again across the states,” Grassley wrote, “suggesting that top prescribers stand out not only against other providers in their state, but against the very top prescribers in those states.”

Last April, Grassley asked Minnesota authorities for a list of 10 doctors who submitted the most claims to the Department of Human Services for prescriptions of such specific antipsychotics as Seroquel and such narcotics as OxyContin.

The state provided the information in May. It also conducted its own review to determine whether the prescriptions appeared appropriate, and whether the top prescribers of antipsychotics were in appropriate specialties, such as psychiatry.

A department spokeswoman said no formal investigations were launched as a result of the review.

None of the doctors on the Minnesota list appeared to approach the excesses Grassley highlighted in other states. Several are on staff at rural mental health centers, which puts them in a position to issue more prescriptions.

Roseville psychiatrist Dr. Roger Johnson stood out on the list, issuing 1,605 prescriptions for Seroquel to patients in Minnesota’s managed-care and fee-for-service Medicaid programs in 2009 — up from 916 prescriptions in 2008. Documents show that his claims to the fee-for-service program alone approached $450,000 last year. The next closest doctor billed the state for just 688 Seroquel prescriptions last year.

Read entire article here:  http://www.startribune.com/lifestyle/health/105576013.html?page=2&c=y

« Return to news items


Share